No single PRO achieved consensus, but threshold scores between 85 and 90 were established for PROs concerning patient performance. Conclusions The consensus identified six measures important for ...

Enterprises need a new way to organize and interrogate their audience touchpoints—and move more effectively toward larger, long-term objectives. Outcome-based marketing is a discipline gaining ...

Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of ...

Clears the way to finalize Phase 3 protocol and recruit sites for U.S. Phase 3 substantially funded by $17.0 million CPRIT grant and $8.5 million Company match Biodexa Pharmaceuticals PLC ...

External Affairs Minister S Jaishankar on Thursday extended India's full backing to Brazil's presidency for a successful and ...

External Affairs Minister S Jaishankar on Thursday extended India's full backing to Brazil's presidency for a successful and outcome-oriented COP30.

The Type C meeting followed a productive End of Phase 2 meeting with FDA and the publication of Phase 2 data of eRapa in FAP at six months at Digestive Disease Week in May 2024 and 12 months data at ...

Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP Clears the way to finalize Phase 3 protocol and recruit sites for U.S. Phase 3 ...